![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, August 28, 2014 10:54:25 AM
Novartis: O/S = 2.45B (NVS)
Merck: O/S = 2.9B (MRK)
Pfizer: O/S = 6.34B (PFE)
Johnson & Johnson: O/S = 2.82B (JNJ)
Gilead Sciences: O/S = 1.53B (GILD)
GlaxoSmithKline: O/S = 4.86B (GSK)
and then we ain't so bad
MultiCell Technologies: O/S = 3.9B (MCET)
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM